Accuray to Host ASTRO Investor Meeting on September 16, 2019

September 4, 2019 at 7:30 AM EDT
Presentations will be Live Webcast and Commence at 3:00pm CT

SUNNYVALE, Calif., Sept. 4, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held in Chicago, IL. The presentations will commence at 3:00pm CT (4:00pm ET/1:00pm PT) and will conclude at 5:30pm CT (6:30pm ET/3:30pm PT). 

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

The program will include presentations by Accuray's senior management team and clinical key opinion leaders about the Company's solutions for addressing today's cancer challenges and will also include question and answer sessions. The topics being discussed include: Solutions for Today's Market, the Radixact® System and the advanced Synchrony® Motion Tracking and Correction Technology1, the CyberKnife® System and CyberKnife VOLO™ Optimizer Technology, and U.S. Reimbursement Developments.

Due to the limited space, guests must register to attend Accuray's ASTRO investor meeting. Please RSVP to Michael Polyviou at by Monday, September 9, 2019.

For those not attending the ASTRO meeting, a webcast will be available on the Investor Relations page of the Company's website at A replay of the webcast will also be available on the Company's website following the event.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and sells radiotherapy systems that are intended to make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. Our radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures. For more information, please visit or follow us on Facebook, LinkedIn, Twitter and YouTube.

Michael Polyviou

Beth Kaplan

Investor Relations, EVC Group

Public Relations Director, Accuray

+1 (732) 933-2755

+1 (408) 789-4426

1 "Synchrony® Motion Tracking and Correction Technology" is synonymous with the development name: "Motion Tracking and Compensation Feature for the Radixact® Treatment Delivery System"


Cision View original content to download multimedia:

SOURCE Accuray Incorporated